3D illustration of a tumor on a black background. The tumor has recruited blood vessels to grow into it from a main artery running at the bottom of the photo. Around the tumor, purple, pink, and blue immune cells try to enter the tumor microenvironment but are stopped.
| 2 min read
Researchers at Cellectis leveraged gene editing to create a CAR T cell that acts in an IF/THEN system.

CAR T cells

An illustration of a B cell secreting autoantibodies.

Autoimmune Diseases: An Alternative Application for Immunotherapy

Chimeric antigen receptor binds to a membrane surface protein on a cancer cell

Enhancing CAR T Cell Generation with Nonviral Genetic Engineering

An illustration showing the DNA inside an immune cell. Other immune cells are shown in the background. 

Keeping CAR T Cells Sharp 

3D rendered RNA strand

MEGA CRISPR: Engineering Better Immunotherapies with RNA Editing

TK

Infographic: Understanding CAR-T vs TCR Approaches

3D Rendering of Molecular Interaction in CAR Chimeric Antigen Receptor

Next-generation CAR and TCR Cancer Therapies

3D illustration of a lymphocyte in white and green.

A Quest for the Holy Grail of Cancer Targets

A Master Regulator of Gene Expression

Bugs as Drugs to Boost Cancer Therapy

Trending

Kirsty Wright is searching for evidence in a missing persons investigation. She is wearing a blue shirt and glasses. Behind her is dense vegetation and police procedural tape.

How a Forensic Biologist Exposed a DNA Lab Scandal That Shook Australia

Photo of John Calhoun crouches within his rodent utopia-turned-dystopia

Universe 25 Experiment

Hands holding an older woman’s hands.

One Gene Influences 75 Percent of Alzheimer’s Disease Cases

A picture of Rohita Roy, a postdoc at Stanford University.

Postdoc Portrait: Rohita Roy

Multimedia

The Scientist Placeholder Image

From Data to Discovery: Omics in Therapeutic Innovation

The Scientist Placeholder Image

Exploring Organoids for Disease Modeling Research

February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies